Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 01/07/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 305613 publications

Correction to "Real-World Data on Inotuzumab Ozogamicin for Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia: A GRELAL-Chile Study".

Correction to "Real-World Data on Inotuzumab Ozogamicin for Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia: A GRELAL-Chile Study".

Journal: Cancer medicine
Published: December 16, 2025

Quercetin induces apoptosis and autophagy in pediatric acute lymphoblastic leukemia by regulating miR-367/KLF4/JNK signaling axis.

Quercetin induces apoptosis and autophagy in pediatric acute lymphoblastic leukemia by regulating miR-367/KLF4/JNK signaling axis.

Journal: Leukemia & lymphoma
Published: December 16, 2025

Sepsis and mucositis-related biomarkers in adult hematologic patients with febrile neutropenia.

Sepsis and mucositis-related biomarkers in adult hematologic patients with febrile neutropenia.

Journal: Leukemia & lymphoma
Published: December 16, 2025

Targeting IMPDH to inhibit SAMHD1 in KMT2A-rearranged leukaemia.

Targeting IMPDH to inhibit SAMHD1 in KMT2A-rearranged leukaemia.

Journal: Cell cycle (Georgetown, Tex.)
Published: December 16, 2025

Fluorescence in situ hybridization supplements to conventional karyotype for detecting aberration of chromosome 5, 7, or 17 in newly diagnosed acute myeloid leukemia.

Fluorescence in situ hybridization supplements to conventional karyotype for detecting aberration of chromosome 5, 7, or 17 in newly diagnosed acute myeloid leukemia.

Journal: Hematology (Amsterdam, Netherlands)
Published: December 16, 2025

Prognostic factors and survival outcomes of first CNS relapse in childhood acute lymphoblastic leukemia: results from the ALL-IC REL 2016 study.

Prognostic factors and survival outcomes of first CNS relapse in childhood acute lymphoblastic leukemia: results from the ALL-IC REL 2016 study.

Journal: Leukemia & lymphoma
Published: December 16, 2025

Daratumumab bortezomib and dexamethasone in transplant ineligible newly diagnosed elderly myeloma patients (AMN006)-a trial by Asian Myeloma Network (NCT03695744).

Daratumumab bortezomib and dexamethasone in transplant ineligible newly diagnosed elderly myeloma patients (AMN006)-a trial by Asian Myeloma Network (NCT03695744).

Journal: Leukemia & lymphoma
Published: December 16, 2025

Multiple myeloma in Mexico: a retrospective study on long-term survival in a publicly insured cohort.

Multiple myeloma in Mexico: a retrospective study on long-term survival in a publicly insured cohort.

Journal: Leukemia & lymphoma
Published: December 16, 2025

Serological pseudoprogression of multiple myeloma after treatment with teclistamab.

Serological pseudoprogression of multiple myeloma after treatment with teclistamab.

Journal: Leukemia & lymphoma
Published: December 16, 2025

Targeting CREB remodels the immune microenvironment to enhance immunotherapy responses in pancreatic cancer.

Targeting CREB remodels the immune microenvironment to enhance immunotherapy responses in pancreatic cancer.

Journal: bioRxiv : the preprint server for biology
Published: December 15, 2025

Intensivist and Hematologist Perceptions of Prognosis of Critically Ill Patients with Hematologic Malignancies.

Intensivist and Hematologist Perceptions of Prognosis of Critically Ill Patients with Hematologic Malignancies.

Journal: Journal of intensive care medicine
Published: December 15, 2025

PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs in Japan; encorafenib for colorectal cancer, daratumumab for multiple myeloma, repotrectinib for NTRK-fusion positive solid tumors, and venetoclax for leukemia.

PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs in Japan; encorafenib for colorectal cancer, daratumumab for multiple myeloma, repotrectinib for NTRK-fusion positive solid tumors, and venetoclax for leukemia.

Journal: International journal of clinical oncology
Published: December 15, 2025
Showing 1-12 of 305,613

Last Updated: 01/07/2026